Pak-Gulf Leasing Company Board Reviews Annual Accounts

Karachi: Pak-Gulf Leasing Company Limited’s Board of Directors convened today, September 20, 2024, at the company’s registered office, to scrutinize the annual accounts for the fiscal year that concluded on

Calcorp Limited Convenes Urgent Board Meeting

Karachi: Calcorp Limited has announced an emergent board meeting set for September 23, 2024, which will take place in Karachi and via a web link. The session is intended to

Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users

VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone — surpassing 45 million users worldwide, overtaking its competitors becoming the fourth largest crypto exchange by trading volume. The platform boasts as the fastest growing

Read More

Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users

VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone — surpassing 45 million users worldwide, overtaking its competitors becoming the fourth largest crypto exchange by trading volume. The platform boasts as the fastest growing

Read More

Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users

VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone — surpassing 45 million users worldwide, overtaking its competitors becoming the fourth largest crypto exchange by trading volume. The platform boasts as the fastest growing

Read More

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced that the underwriters of its previously announced upsized initial public offering of 13,235,294 shares of

Read More